Abstract:This study focused on the design of a novel pH responsive nanoparticle drug delivery system (NDDS) with high biocompatibility and water solubility. The designed system was used for doxorubicin (DOX) delivery at tumor sites in a controlled manner. These innovative nanoparticles are soluble in physiological solutions besides water. In this study, pretreated gamma-polyglutamic acid (gamma-PGA) aqueous solutions were loaded into composites of graphene oxide (GO) covalently linked with chitosan oligosaccharide (CO) to fabricate GO-CO-gamma-PGA via amidation. The characterizations of the synthesized samples were carried out by using fourier transform infrared spectrometer (FTIR), X-ray photoelectron spectrometer (XPS), ultraviolet- visible spectrophotometer (UV-Vis), transmission electron microscopy (TEM), atomic force microscope (AFM) and zeta potential. Furthermore, drug loading and release behaviors from GO-CO-gamma-PGA were studied. The DOX loading in the constructed nanocarriers (GO-CO-gamma-PGA-DOX) resulted in controlled and sustained release. The results of cell experiments revealed that the synthesized composites, which were easily transferred into cells, showed low toxicity and exhibited excellent antitumor effect due to its good connection with DOX. In addition, the composite nanoparticles caused the cell cycle arrest of Hela cells at the G(2)/M phase. Western blot results indicated that GO-CO-gamma-PGA-DOX downregulated the expression of Bcl-2 protein but upregulated Bax protein expression, which triggered the release of cytochrome C (Cytc). This condition further activated caspase-3, cleaved the substrate of poly ADP-ribose polymerase (PARP), and caused cell apoptosis. These results demonstrated that GO-CO-gamma-PGA-DOX induces apoptosis via the intrinsic mitochondrial apoptotic pathway. Hence GO-CO-gamma-PGA composites have promising application in the field of biomedicine.

Functional Graphene Oxide As Cancer-Targeted Drug Delivery System to Selectively Induce Oesophageal Cancer Cell Apoptosis

Functionalized Graphene Oxide As a Nanocarrier for Loading and Delivering of Oridonin

Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs

A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites

Amphiphilic Prodrug-Decorated Graphene Oxide As a Multi-Functional Drug Delivery System for Efficient Cancer Therapy.

Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy

GE11 Peptide Conjugated Selenium Nanoparticles for EGFR Targeted Oridonin Delivery to Achieve Enhanced Anticancer Efficacy by Inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK Pathways

Multi-functionalized Graphene Oxide Based Anticancer Drug-Carrier with Dual-Targeting Function and Ph-Sensitivity

Recent Progress of Functionalised Graphene Oxide in Cancer Therapy

Dual-Functional Nanographene Oxide As Cancer-Targeted Drug-Delivery System to Selectively Induce Cancer-Cell Apoptosis.

Construction of an exosome-functionalized graphene oxide based composite bionic smart drug delivery system and its anticancer activity

Graphene-based Nanomaterials and Their Potentials in Advanced Drug Delivery and Cancer Therapy

Fabrication and Antitumor Mechanism of a Nanoparticle Drug Delivery System: Graphene Oxide/Chitosan Oligosaccharide/γ‐Polyglutamic Acid Composites for Anticancer Drug Delivery

GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.

Delivery of Oridonin and Methotrexate Via PEGylated Graphene Oxide

Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy

Biofunctionalized graphene oxide nanosheet for amplifying antitumor therapy: Multimodal high drug encapsulation, prolonged hyperthermal window, and deep-site burst drug release

Targeted Delivery of SNX-2112 by Polysaccharide-Modified Graphene Oxide Nanocomposites for Treatment of Lung Cancer

Graphene Oxide-Based Nanocomposite Enabled Highly Efficient Targeted Synergistic Therapy for Colorectal Cancer

Dual-Sensitive Graphene Oxide Loaded with Proapoptotic Peptides and Anticancer Drugs for Cancer Synergetic Therapy

Functionalized Graphene Oxide with Hepatocyte Targeting As Anti-Tumor Drug and Gene Intracellular Transporters